RxDoctor Payments DataLook up a doctor →

Celinde Strohl, MD

Internal Medicine · Littleton, CONPI 1912990409

Payments from drug & device makers

$14,241in general payments, 2019–2025

Across 804 payments — averaging $17.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$2K
  • AstraZeneca$1K
  • Novo Nordisk$1K
  • Pfizer$988
  • Lilly USA, LLC$562
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)146$2,451
Amgen(2 entities)89$1,674
AstraZeneca(2 entities)42$1,095
Novo Nordisk56$1,013
Pfizer70$988
Lilly USA, LLC38$562
Johnson & Johnson(2 entities)27$443
Novartis24$429
GSK20$404
Antares Pharma, Inc.23$401
Astellas Pharma US Inc15$320
Esperion Therapeutics, Inc.14$313
Eisai Inc.26$307
Amarin Pharma, Inc.19$291
Boehringer Ingelheim14$248
Radius Health, Inc.11$204
E.r. Squibb & Sons, L.L.C.11$201
Bayer10$193
Biohaven Pharmaceutical Holding Company Ltd.7$184
Phathom Pharmaceuticals, Inc.4$181
Ironwood Pharmaceuticals, Inc9$171
Exact Sciences8$159
Merck9$133
Kowa Pharmaceuticals America, Inc.9$126
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$111
Sumitomo Pharma America, Inc.6$110
Sanofi-aventis U.S. LLC5$97
Otsuka America Pharmaceutical, Inc.5$96
Sunovion Pharmaceuticals Inc.6$83
Edwards Lifesciences3$79
Currax Pharmaceuticals LLC5$70
Boston Scientific2$55
Inspire Medical Systems, Inc.2$53
Insmed, Inc.3$53
IBSA Pharma Inc.3$47
Abbott3$45
Medtronic3$44
Endo Pharmaceuticals Inc.3$43
Bausch Health US, LLC2$41
Alfasigma USA, Inc.2$34
Lucid Diagnostics Inc.2$34
Inogen, Inc.2$33
Alkermes, Inc.2$32
BETA Bionics, Inc.1$31
Clarus Therapeutics Inc.3$30
Biohaven Pharmaceuticals, Inc.2$29
Avanir Pharmaceuticals, Inc.2$28
Therapeuticsmd, Inc.2$27
Sanofi Pasteur Inc.1$26
Neuronetics, Inc.1$25
Arbor Pharmaceuticals, Inc.1$22
Ultragenyx Pharmaceutical Inc.1$21
GE HealthCare1$20
Pulmonx Corporation1$19
Nestle Healthcare Nutrition Inc.1$19
Halozyme Inc1$19
Duchesnay USA Incorporated1$18
Aimmune Therapeutics, Inc.1$18
Ascend Therapeutics US, LLC1$18
Lundbeck LLC1$18

How this compares

$14,241 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado →

Medicare billing

Part B allowed, 2024
$190,240
Medicare patients
353
Services billed
2,573

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Littleton

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →